Loading…

Medical Research Finder

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

Chlorambucil + Rituximab & Chronic lymphocytic leukemia (CLL) / Small lymphocytic lymphoma (SLL)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

EMA Approval: Rituximab is authorized for Chronic Lymphocytic Leukemia (CLL) in combination with chemotherapy, which includes chlorambucil-based regimens. The European Medicines Agency (EMA) does not restrict the combination to specific chemotherapy agents.

see also:
B-lymphocyte antigen CD20 (CD20) antibodies + DNA alkylating agents & Chronic lymphocytic leukemia (CLL) / Small lymphocytic lymphoma (SLL)
[Chronic lymphocytic leukemia (CLL) / Small lymphocytic lymphoma (SLL) & Drugs/Treatments](brain://ZE9qn8cFKk694k0gn0Sm5Q/ChronicLymphocyticLeukemiaCllSmallLymphoc…

7/1/2026